Products for Research Use Only
RegisterLogin

HLDA-212

CAT: 0804-HY-173499Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-173499Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
HLDA-212 (Compound 43) is a bifunctional small molecule targeting HaloTag-tagged protein (Target Protein, TP) and Aurora kinase A/B (AURKA/B, Effector Protein, EP) . HLDA-212 binds to TP and EP to form a stable ternary complex (TP:RIPTAC:EP), inhibiting the cell-survival function of EP and inducing apoptosis in TP-expressing cancer cells. HLDA-212 shows antiproliferative activity (GI50 of 0.011 μM) in 293_HFL cells. HLDA-212 is promising for research of cancers with high TP expression (such as prostate cancer and hematological malignancies) [1].
CAS Number
3077339-88-6
UNSPSC
12352005
Target
Apoptosis; Aurora Kinase
Related Pathways
Apoptosis; Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Smiles
CC[C@H](C(N1CCCC[C@H]1C(O[C@H](CCC2=CC=C(OC)C(OC)=C2)C3=CC=CC(OCC(N(C)CCOCCOCCOCCOCCOCCOCCNS(=O)(C4=CC=C(NC5=NC=C(Br)C(NC6=C(C(N)=O)C(F)=CC=C6)=N5)C=C4)=O)=O)=C3)=O)=O)C7=CC(OC)=C(OC)C(OC)=C7
Molecular Formula
C70H90BrFN8O19S
Molecular Weight
1478.47
References & Citations
[1]Ma Z, et al. RIPTACs: A groundbreaking approach to drug discovery. Drug Discov Today. 2023 Nov;28 (11) :103774.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Aurora A; Aurora B

Related Products

CatalogName
HY-156820-01HLDA-221
HY-168061HldA/E-IN-1
HY-137977-01DMU-212
HY-101324MK-212
HY-D1005A12Poloxamer 212 (L72)
HY-158242Antibacterial agent 212
HY-101324A-01MK-212 (monohydrochloride)
HY-163558Anticancer agent 212
HY-W999585CRBN ligand-212
HY-101324ARMK-212 (monohydrochloride) (Standard)

Alternative Products

CatalogName
T207415-01HLDA-212
GTR19218209-01HLDA-221
T200513-01HldA/E-IN-1
BA2893-50DMU-212
RR212-RK4.IRoboRocker 212
GTR19192256YM 212

Popular Products